Financials disclosed in this offering
FY2022–FY2023 · hover for sourceThe fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Amendments to this offering
2 amendments- Apr 30, 2025
- Deadline Apr 30, 2025 → Jun 30, 2025
- Maximum $820.8K → $1.2M
“Issuer is updating their financial statements per the most recent fiscal year, increasing their offering maximum to $1,234,999.26, and extending their campaign end date to June 30th, 2025.”
Form C/A on EDGAR ↗ - Mar 21, 2025
- Deadline Apr 14, 2025 → Apr 30, 2025
- Target $124K → $20K
- Price $10.92 → $10.34
“Adj. rev. from $1.7M ARR to $143K MRR. Chgd share price to $10.34. Upd. valuation to $23.09M. Added $685K in conv. debt. Rev. shares to 2.23M. Upd. debt maturities. Added FWD-looking disclaimer. Extended deadline.”
Form C/A on EDGAR ↗
Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.
Deal terms
Perks
Offering details
Links & provenance
0001665160-25-000057
Last synced Aug 18, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.